New Current Report Filed with the SEC: 8-K – Sorrento Therapeutics, Inc. (0000850261) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC). Details of the current report are:

8-K – Sorrento Therapeutics, Inc. (0000850261) (Filer)
Filed: 2015-09-30 AccNo: 0001193125-15-333328 Size: 37 KB

Item 1.01: Entry into a Material Definitive Agreement

Item 9.01: Financial Statements and Exhibits
Filing Date: 2015-09-30T08:05:05-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: